Insider Transactions in Q1 2022 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2022
|
Steven Prestrelski Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,228
-1.93%
|
$22,456
$2.42 P/Share
|
|
Feb 22
2022
|
Steven Prestrelski Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,228
+1.9%
|
$0
$0.69 P/Share
|
|
Jan 31
2022
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-0.05%
|
$1,500
$2.11 P/Share
|
|
Jan 31
2022
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,307
-0.52%
|
$4,614
$2.11 P/Share
|
|
Jan 31
2022
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,448
-0.29%
|
$8,896
$2.11 P/Share
|
|
Jan 31
2022
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,497
-0.31%
|
$14,994
$2.11 P/Share
|
|
Jan 29
2022
|
Steven Pieper Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,460
-0.21%
|
$6,920
$2.11 P/Share
|
|
Jan 29
2022
|
Kenneth Erland Johnson Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,497
-1.67%
|
$14,994
$2.11 P/Share
|
|
Jan 29
2022
|
Beth Hecht Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,037
-0.9%
|
$28,074
$2.11 P/Share
|
|
Jan 29
2022
|
John Patrick Shannon Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
15,692
-0.65%
|
$31,384
$2.11 P/Share
|
|
Jan 03
2022
|
Steven Prestrelski Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+11.63%
|
-
|
|
Jan 03
2022
|
Paul R Edick Director |
BUY
Grant, award, or other acquisition
|
Direct |
600,000
+29.88%
|
-
|
|
Jan 03
2022
|
John Patrick Shannon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+28.77%
|
-
|
|
Jan 03
2022
|
Beth Hecht Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+34.0%
|
-
|
|
Jan 03
2022
|
Kenneth Erland Johnson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+31.14%
|
-
|
|
Jan 03
2022
|
Steven Pieper Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+33.97%
|
-
|